TriSalus Life Sciences (TLSI) CMO awarded RSUs and 120,000-share option grant

Rhea-AI Filing Summary

TriSalus Life Sciences, Inc. Chief Medical Officer Richard Henry received new equity compensation in the form of restricted stock units and stock options. He was granted 60,000 shares of common stock as restricted stock units, which will vest in four equal annual installments starting on June 29, 2027, assuming continued service. He also received an employee stock option for 120,000 shares of common stock at an exercise price of $4.74 per share, vesting over four years with one-fourth vesting on June 29, 2027 and the remainder monthly thereafter. Following these grants, he directly holds 90,000 shares of common stock and 253,000 stock options.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Marshall Richard Henry

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	120,000	$0.00	--
Grant/Award	Common Stock	60,000	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 253,000 shares (Direct, null); Common Stock — 90,000 shares (Direct, null)

Footnotes (1)

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Key Figures

RSU grant size: 60,000 shares Option grant size: 120,000 shares Option exercise price: $4.74 per share +5 more

8 metrics

RSU grant size 60,000 shares Restricted stock units granted June 29, 2026

Option grant size 120,000 shares Employee stock option granted June 29, 2026

Option exercise price $4.74 per share Exercise price for 120,000-share option

Option expiration June 29, 2036 Expiration date of employee stock option

Common shares after grant 90,000 shares Total common stock held directly after RSU grant

Options after grant 253,000 options Total options held directly after new option award

RSU vesting schedule 4 annual installments RSUs vest annually starting June 29, 2027

Option vesting pattern 1/4 at 1 year, then monthly Option vests over four years from June 29, 2026

Key Terms

restricted stock units, RSU Award, vesting commencement date, Employee Stock Option, +1 more

5 terms

restricted stock units financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU Award financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

vesting commencement date financial

"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

Employee Stock Option financial

"Employee Stock Option (right to buy)"

An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.

continuous service financial

"subject to the Reporting Person's continuous service with the Issuer on each respective vesting date"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 04:33 PM Accepted by SEC EDGAR 06/29/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Marshall Richard Henry

(Last) (First) (Middle)

6272 W. 91ST AVENUE

(Street)

WESTMINSTER COLORADO 80031

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TriSalus Life Sciences, Inc. [ TLSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/29/2026		A		60,000(1)	A	$0	90,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$4.74	06/29/2026		A		120,000		(2)	06/29/2036	Common Stock	120,000	$0	253,000	D

Explanation of Responses:

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

2. One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.

Remarks:

	/s/ Mary Szela, Attorney-in-Fact	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did TriSalus Life Sciences (TLSI) grant to its CMO?

TriSalus granted Chief Medical Officer Richard Henry 60,000 restricted stock units and an option for 120,000 shares. These awards provide long-term equity incentives tied to company performance and continued employment over several years.

How do the new restricted stock units for TLSI’s CMO vest?

The 60,000 restricted stock units vest in four equal annual installments starting June 29, 2027. Each yearly tranche requires Richard Henry to remain in service with TriSalus Life Sciences through the applicable vesting date to receive the underlying shares.

What are the key terms of the new stock option granted by TLSI?

The employee stock option covers 120,000 shares of TriSalus common stock with a $4.74 exercise price. One-fourth vests on June 29, 2027, and the remaining shares vest monthly over 36 months, subject to continuous service, with expiration on June 29, 2036.

How many TriSalus (TLSI) shares does the CMO hold after these grants?

After these grants, Richard Henry directly holds 90,000 shares of TriSalus common stock and 253,000 stock options. This reflects his updated equity position as reported in the Form 4 insider trading report filed with the SEC.

Are the recent TLSI insider transactions open-market buys or compensation grants?

The recent insider transactions are compensation-related grants, not open-market purchases or sales. Both the 60,000 restricted stock units and 120,000-share stock option were awarded to the Chief Medical Officer as part of his equity compensation package.